COX-2 Inhibition mediated anti-angiogenic activatable prodrug potentiates cancer therapy in preclinical models

Kim, HS; Sharma, A; Ren, WX; Han, JY; Kim, JS

Kim, JS (reprint author), Korea Univ, Dept Chem, Seoul 02841, South Korea.; Ren, WX (reprint author), Southwest Med Univ, Dept Radiol, Affiliated Hosp, Luzhou 646000, Sichuan, Peoples R China.; Han, JY (reprint author), Hyupsung Univ, Dept Biol Sci, Lab S

BIOMATERIALS, 2018; 185 (): 63

Abstract

Anti-angiogenesis, i.e., blocking the angiogenic pathway, has been considered as an important component in current cancer therapeutic modalities. Howe......

Full Text Link